Annual Current Liabilities
$109.33 M
+$65.88 M+151.66%
31 December 2023
Summary:
Standard BioTools annual total current liabilities is currently $109.33 million, with the most recent change of +$65.88 million (+151.66%) on 31 December 2023. During the last 3 years, it has risen by +$55.08 million (+101.53%). LAB annual current liabilities is now at all-time high.LAB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$120.61 M
-$3.19 M-2.58%
30 September 2024
Summary:
Standard BioTools quarterly total current liabilities is currently $120.61 million, with the most recent change of -$3.19 million (-2.58%) on 30 September 2024. Over the past year, it has increased by +$68.81 million (+132.85%). LAB quarterly current liabilities is now -2.58% below its all-time high of $123.81 million, reached on 30 June 2024.LAB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +151.7% | +132.8% |
| 3 y3 years | +101.5% | +155.1% |
| 5 y5 years | +190.9% | +267.5% |
LAB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +151.7% | -2.6% | +182.0% |
| 5 y | 5 years | at high | +233.1% | -2.6% | +267.5% |
| alltime | all time | at high | +1433.5% | -2.6% | +1591.9% |
Standard BioTools Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $120.61 M(-2.6%) |
| June 2024 | - | $123.81 M(+1.9%) |
| Mar 2024 | - | $121.55 M(+11.2%) |
| Dec 2023 | $109.33 M(+151.7%) | $109.33 M(+111.1%) |
| Sept 2023 | - | $51.80 M(+10.6%) |
| June 2023 | - | $46.84 M(+7.0%) |
| Mar 2023 | - | $43.79 M(+0.8%) |
| Dec 2022 | $43.44 M(-12.4%) | $43.44 M(-5.9%) |
| Sept 2022 | - | $46.17 M(+7.9%) |
| June 2022 | - | $42.77 M(-9.3%) |
| Mar 2022 | - | $47.17 M(-4.8%) |
| Dec 2021 | $49.57 M(-8.6%) | $49.57 M(+4.8%) |
| Sept 2021 | - | $47.29 M(-10.5%) |
| June 2021 | - | $52.85 M(-1.3%) |
| Mar 2021 | - | $53.53 M(-1.3%) |
| Dec 2020 | $54.25 M(+65.3%) | - |
| Dec 2020 | - | $54.25 M(+26.8%) |
| Sept 2020 | - | $42.79 M(+11.6%) |
| June 2020 | - | $38.35 M(+8.4%) |
| Mar 2020 | - | $35.36 M(+7.7%) |
| Dec 2019 | $32.82 M(-12.7%) | - |
| Dec 2019 | - | $32.82 M(-1.6%) |
| Sept 2019 | - | $33.37 M(-10.6%) |
| June 2019 | - | $37.32 M(+9.2%) |
| Mar 2019 | - | $34.18 M(-9.0%) |
| Dec 2018 | $37.58 M(+12.3%) | $37.58 M(-3.3%) |
| Sept 2018 | - | $38.87 M(+6.0%) |
| June 2018 | - | $36.65 M(+8.7%) |
| Mar 2018 | - | $33.70 M(+0.7%) |
| Dec 2017 | $33.47 M | $33.47 M(+5.0%) |
| Sept 2017 | - | $31.88 M(-7.1%) |
| June 2017 | - | $34.32 M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $31.29 M(+6.1%) |
| Dec 2016 | $29.50 M(-1.9%) | $29.50 M(+5.7%) |
| Sept 2016 | - | $27.91 M(-13.6%) |
| June 2016 | - | $32.31 M(+5.9%) |
| Mar 2016 | - | $30.52 M(+1.5%) |
| Dec 2015 | $30.08 M(+2.4%) | $30.08 M(+9.5%) |
| Sept 2015 | - | $27.48 M(-5.0%) |
| June 2015 | - | $28.93 M(+16.2%) |
| Mar 2015 | - | $24.90 M(-15.2%) |
| Dec 2014 | $29.39 M(+63.7%) | $29.39 M(+7.6%) |
| Sept 2014 | - | $27.31 M(0.0%) |
| June 2014 | - | $27.31 M(+6.1%) |
| Mar 2014 | - | $25.74 M(+43.4%) |
| Dec 2013 | $17.95 M(+54.8%) | $17.95 M(+19.3%) |
| Sept 2013 | - | $15.04 M(+29.4%) |
| June 2013 | - | $11.63 M(+0.8%) |
| Mar 2013 | - | $11.54 M(-0.5%) |
| Dec 2012 | $11.60 M(-42.5%) | $11.60 M(-11.6%) |
| Sept 2012 | - | $13.13 M(-11.1%) |
| June 2012 | - | $14.77 M(-16.8%) |
| Mar 2012 | - | $17.74 M(-12.0%) |
| Dec 2011 | $20.17 M(+9.0%) | $20.17 M(+2.6%) |
| Sept 2011 | - | $19.66 M(+10.7%) |
| June 2011 | - | $17.76 M(-4.2%) |
| Mar 2011 | - | $18.55 M(+0.2%) |
| Dec 2010 | $18.51 M(+159.7%) | $18.51 M(+61.8%) |
| Sept 2010 | - | $11.44 M(+60.5%) |
| Dec 2009 | $7.13 M(-16.3%) | $7.13 M(-16.3%) |
| Dec 2008 | $8.52 M(-26.4%) | $8.52 M(-45.9%) |
| June 2008 | - | $15.75 M(+36.1%) |
| Dec 2007 | $11.57 M(+61.9%) | $11.57 M |
| Dec 2006 | $7.15 M | - |
FAQ
- What is Standard BioTools annual total current liabilities?
- What is the all time high annual current liabilities for Standard BioTools?
- What is Standard BioTools annual current liabilities year-on-year change?
- What is Standard BioTools quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Standard BioTools?
- What is Standard BioTools quarterly current liabilities year-on-year change?
What is Standard BioTools annual total current liabilities?
The current annual current liabilities of LAB is $109.33 M
What is the all time high annual current liabilities for Standard BioTools?
Standard BioTools all-time high annual total current liabilities is $109.33 M
What is Standard BioTools annual current liabilities year-on-year change?
Over the past year, LAB annual total current liabilities has changed by +$65.88 M (+151.66%)
What is Standard BioTools quarterly total current liabilities?
The current quarterly current liabilities of LAB is $120.61 M
What is the all time high quarterly current liabilities for Standard BioTools?
Standard BioTools all-time high quarterly total current liabilities is $123.81 M
What is Standard BioTools quarterly current liabilities year-on-year change?
Over the past year, LAB quarterly total current liabilities has changed by +$68.81 M (+132.85%)